Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04775056
Status:
WITHDRAWN
Last Update Posted:
2022-08-03
First Post:
2021-02-26
Brief Title:
A Study to Evaluate Vaccines Against COVID-19 in the Real World
Sponsor:
Humanity Health Medical Group Limited
Organization:
Humanity Health Medical Group Limited
Study Overview
Official Title:
A Study to Describe the Safety Tolerability Immunogenicity and Efficacy of Vaccines Against COVID-19 in the Real World
Status:
WITHDRAWN
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No sponsor
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection and the resulting coronavirus disease 2019 COVID-19 have afflicted tens of millions of people in a worldwide pandemic Considering its high mortality and rapid spread an effective vaccine is urgently needed to control this pandemic Recently mass vaccination campaigns using newly approved vaccines ranging from conventional viral and protein-based vaccines to those that are more cutting edge including DNA- and mRNA-based vaccines are beginning in many parts of the world Randomized clinical trials of different vaccines reported efficacies for preventing COVID-19 in the range of 50 to 95
Although these randomized clinical trials are considered the gold standard for evaluating intervention effects they have notable limitations of sample size and subgroup analysis restrictive inclusion criteria and a highly controlled setting that may not be replicated in a mass vaccine rollout
The aim of this study is to evaluate the safety tolerability immunogenicity and efficacy of different vaccines against COVID-19 under real-world practice conditions
Although these randomized clinical trials are considered the gold standard for evaluating intervention effects they have notable limitations of sample size and subgroup analysis restrictive inclusion criteria and a highly controlled setting that may not be replicated in a mass vaccine rollout
The aim of this study is to evaluate the safety tolerability immunogenicity and efficacy of different vaccines against COVID-19 under real-world practice conditions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None